Cor Vasa 2019, 61(4):e378-e384 | DOI: 10.1016/j.crvasa.2018.09.007
(Prediction of long-term renal denervation efficacy)
- a Centrum pro hypertenzi, III. interní klinika, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice v Praze, Praha
- b Radiodiagnostická klinika, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice v Praze, Praha
- c Klinika anesteziologie a resuscitace, 3. lékařská fakulta Univerzity Karlovy a Fakultní nemocnice Královské Vinohrady, Praha
- d Klinika nefrologie, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice v Praze, Praha
- e I. interní klinika - kardiologická, Lékařská fakulta Univerzity Palackého a Fakultní nemocnice Olomouc, Olomouc
- f Kardiocentrum, Nemocnice Podlesí, Třinec
Diversity of blood pressure response and great variability within studies emphasise the need to identify predictors of renal denervation efficacy. Previous studies identified various predictors within periods of 3-6 months. The goal of the current study is to examine the possible predictors of sustained decline of blood pressure (BP) after renal denervation in a long-term period of 2 years. Evaluated patients were either randomised in the original PRAGUE-15 study or were pilot patients, meeting the same inclusion criteria of true-resistant hypertension. Patients were considered as responsive when the decline of 24h systolic BP ≥ 10 mmHg was present 6, 12 and 24 months after the procedure. In addition, analysis for separate visits was performed. Denervation was performed using the unipolar Symplicity Renal Denervation System. Extensive assessment of computed tomography angiography by numerous measurements including morphology of the renal arteries was performed. A total of 48 patients were analysed, with 27 patients suitable for long-term prediction. Five of the 27 patients were identified as long-term responders with average 24h BP decline of 20/9 mmHg. Strongest predictors of BP decline were higher baseline 24h systolic blood pressure (p = 0.01) and higher diameter of the left renal artery (p = 0.04). Only a minority of denervated patients exhibited sustained BP decline. Higher baseline BP and higher renal artery diameter might be the strongest predictors. Our findings might theoretically support the actual hypothesis of the necessity to ablate the distal parts of the renal artery (these conditions might allow such ablation to be performed).
Keywords: Ambulatory blood pressure monitoring, Blood pressure, Renal denervation, Resistant hypertension
Published: August 11, 2019 Show citation
Attachments
Download file | Tables S1-S4 Tabulky_S1-S4.pdf |
References
- Schlaich MP, Sobotka PA, Krum H, et al. Renal sympathetic nerve ablation for uncontrolled hypertension. N Engl J Med 2009;361:932-934.
Go to original source...
Go to PubMed...
- Esler MD, Krum H, Sobotka PA, et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010;376:1903-1909.
Go to original source...
Go to PubMed...
- Bhatt DL, Kandzari DE, O'Neill WW, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014;370:1393-1401.
Go to original source...
Go to PubMed...
- Desch S, Okon T, Heinemann D, et al. Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension. Hypertension 2015;65:1202-1208.
Go to original source...
Go to PubMed...
- Fadl Elmula FE, Hoffmann P, Larstorp AC, et al. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension. Hypertension 2014;63:991-999.
Go to original source...
Go to PubMed...
- Rosa J, Widimský P, Toušek P, et al. Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension: six-month results from the PRAGUE-15 study. Hypertension 2015;65:407-413.
Go to original source...
Go to PubMed...
- Fadl Elmula FE, Jin Y, Yang WY, et al., European Network Coordinating Research On Renal Denervation. Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension. Blood Press 2015;24:263-274.
Go to original source...
Go to PubMed...
- Azizi M, Sapoval M, Gosse P, et al., Renal Denervation for Hypertension (DENERHTN) investigators. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial. Lancet 2015;385:1957-1965.
Go to original source...
Go to PubMed...
- Jacobs L, Persu A, Huang QF, et al., European Network Coordinating Research on Renal Denervation. Results of a randomized controlled pilot trial of intravascular renal denervation for management of treatment-resistant hypertension. Blood Press 2017;26:321-331.
Go to original source...
Go to PubMed...
- Townsend RR, Mahfoud F, Kandzari DE, et al. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet 2017;390:2160-2170.
Go to original source...
Go to PubMed...
- Azizi M, Schmieder RE, Mahfoud F, et al. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet 2018;391:2335-2345.
Go to original source...
Go to PubMed...
- Kandzari DE, Bohm M, Mahfoud F, et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet 2018;391:2346-2355.
Go to original source...
Go to PubMed...
- Persu A, Jin Y, Azizi M, et al. Blood pressure changes after renal denervation at 10 European expert centers. J Hum Hypertens 2014;28:150-156.
Go to original source...
Go to PubMed...
- Id D, Bertog SC, Ziegler AK, et al. Predictors of Blood Pressure Response: Obesity Is Associated With a Less Pronounced Treatment Response After Renal Denervation. Catheter Cardiovasc Interv 2016;87:E30-E38.
Go to original source...
Go to PubMed...
- Rohla M, Nahler A, Lambert T, et al. Predictors of response to renal denervation for resistant arterial hypertension: a single center experience. J Hypertens 2016;34:123-129.
Go to original source...
Go to PubMed...
- Kandzari DE, Bhatt DL, Brar S, et al. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. Eur Heart J 2015;36:219-227.
Go to original source...
Go to PubMed...
- Persu A, Azizi M, Jin Y, et al. Hyperresponders vs. nonresponder patients after renal denervation: do they differ? J Hypertens 2014;32:2422-2427.
Go to original source...
- Prochnau D, Heymel S, Gobel B, et al. Resistant hypertension: multivariate predictors of blood pressure response to renal denervation. Int J Cardiol 2013;168:3130-3132.
Go to original source...
Go to PubMed...
- Gosse P, Cremer A, Pereira H, et al. Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension). Hypertension 2017;69:494-500.
Go to original source...
Go to PubMed...
- Howard JP, Nowbar AN, Francis DP. Size of blood pressure reduction from renal denervation: insights from meta-analysis of antihypertensive drug trials of 4,121 patients with focus on trial design: the CONVERGE report. Heart 2013;99:1579-1587.
Go to original source...
- Persu A, Gordin D, Jacobs L, et al. Blood pressure response to renal denervation is correlated with baseline blood pressure variability: a patient-level meta-analysis. J Hypertens 2018;36:221-229.
Go to original source...
Go to PubMed...
- Fink GD, Phelps JT. Can we predict the blood pressure response to renal denervation? Auton Neurosci 2017;204:112-118.
Go to original source...
Go to PubMed...
- Okon T, Rohnert K, Stiermaier T, et al. Invasive aortic pulse wave velocity as a marker for arterial stiffness predicts outcome of renal sympathetic denervation. EuroIntervention 2016;12:e684-e692.
Go to original source...
Go to PubMed...
- Hering D, Marusic P, Walton AS, et al. Renal artery anatomy affects the blood pressure response to renal denervation in patients with resistant hypertension. Int J Cardiol 2016;202:388-393.
Go to original source...
- Ewen S, Ukena C, Luscher TF, et al. Anatomical and procedural determinants of catheter-based renal denervation. Cardiovasc Revasc Med 2016;17:474-479.
Go to original source...
Go to PubMed...
- de Jong MR, Adiyaman A, Gal P, et al. Renal Nerve Stimulation-Induced Blood Pressure Changes Predict Ambulatory Blood Pressure Response After Renal Denervation. Hypertension 2016;68:707-714.
Go to original source...
- Weber T, Kellermair J, Witberg KT, et al. Changes in renal artery dimensions are associated with clinical response to radiofrequency renal denervation: a series of studies using quantitative angiography and intravascular ultrasound. J Hypertens 2017;35:2069-2076.
Go to original source...
Go to PubMed...
- Rosa J, Widimský P, Waldauf P, et al. Role of Adding Spironolactone and Renal Denervation in True Resistant Hypertension: One-Year Outcomes of Randomized PRAGUE-15 Study. Hypertension 2016;67:397-403.
Go to original source...
- Rosa J, Zelinka T, Petrák O, et al. Importance of thorough investigation of resistant hypertension before renal denervation: should compliance to treatment be evaluated systematically? J Hum Hypertens 2014;28:684-688.
Go to original source...
Go to PubMed...
- Toušek P, Widimský Jr J, Rosa J, et al. Catheter-based renal denervation versus intensified medical treatment in patients with resistant hypertension: Rationale and design of a multicenter randomized study - PRAGUE-15. Cor Vasa 2014;56:e235-e239.
Go to original source...
- Ceral J, Habrdová V, Voříšek V, et al. Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non- -responsiveness from non-adherence to recommended therapy. Hypertens Res 2011;34:87-90.
Go to original source...
Go to PubMed...
- Štrauch B, Petrák O, Zelinka T, et al. Precise assessment of noncompliance with the antihypertensive therapy in patients with resistant hypertension using toxicological serum analysis. J Hypertens 2013;31:2455-2461.
Go to original source...
Go to PubMed...
- Tomaszewski M, White C, Patel P, et al. High rates of non- -adherence to antihypertensive treatment revealed by high- -performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis. Heart 2014;100:855-861.
Go to original source...
Go to PubMed...
- Čurila K, Rosa J, Toušek P, et al. Technical and safety aspects of renal denervation. Cor Vasa 2014;56:e228-e234.
Go to original source...
- Booth LC, Nishi EE, Yao ST, et al. Reinnervation of renal afferent and efferent nerves at 5.5 and 11 months after catheter-based radiofrequency renal denervation in sheep. Hypertension 2015;65:393-400.
Go to original source...
- Thornton E, Mendiratta-Lala M, Siewert B, Eisenberg RL. Patterns of fat stranding. Am J Roentgenol 2011;197:W1-W14.
Go to original source...
Go to PubMed...
- Fukami H, Takeuchi Y, Kagaya S, et al. Perirenal fat stranding is not a powerful diagnostic tool for acute pyelonephritis. Int J Gen Med 2017;10:137-144.
Go to original source...
Go to PubMed...
- Lee S, Lim D, Lee J, et al. Long-Term Blood Pressure Control Effect of Celiac Plexus Block with Botulinum Toxin. Toxins 2016;8:51.
Go to original source...
Go to PubMed...
- Li M, Galligan J, Wang D, Fink G. The effects of celiac ganglionectomy on sympathetic innervation to the splanchnic organs in the rat. Auton Neurosci 2010;154:66-73.
Go to original source...
Go to PubMed...
- Mahfoud F, Tunev S, Ewen S, et al. Impact of Lesion Placement on Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation. J Am Coll Cardiol 2015;66:1766-1775.
Go to original source...
Go to PubMed...
- Pekarskiy SE, Baev AE, Mordovin VF, et al. Denervation of the distal renal arterial branches vs. conventional main renal artery treatment: a randomized controlled trial for treatment of resistant hypertension. J Hypertens 2017;35:369-375.
Go to original source...
Go to PubMed...
- Sakakura K, Ladich E, Cheng Q, et al. Anatomic assessment of sympathetic peri-arterial renal nerves in man. J Am Coll Cardiol 2014;4:635-643.
Go to original source...
Go to PubMed...
- Mahfoud F, Schmieder RE, Azizi M, et al. Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future. Eur Heart J 2017;38:3272-3281.
Go to original source...
Go to PubMed...
- Tiroch K, Sause A, Szymanski J, et al. Intraprocedural reduction of the veno-arterial norepinephrine gradient correlates with blood pressure response after renal denervation. EuroIntervention 2015;11:824-834.
Go to original source...
Go to PubMed...
- Kjeldsen SE, Persu A, Azizi M. Design of renal denervation studies not confounded by antihypertensive drugs. J Am Soc Hypertens 2015;9:337-340.
Go to original source...
Go to PubMed...
- Persu A, Kjeldsen S, Staessen JA, Azizi M. Renal Denervation for Treatment of Hypertension: a Second Start and New Challenges. Curr Hypertens Rep 2016;18:6.
Go to original source...
Go to PubMed...
- Fadl Elmula FEM, Feng YM, Jacobs L, et al. Sham or no sham control: that is the question in trials of renal denervation for resistant hypertension. A systematic meta-analysis. Blood Press 2017;26:195-203.
Go to original source...
Go to PubMed...
- De Jager RL, Sanders MF, Bots ML, et al. Renal denervation in hypertensive patients not on blood pressure lowering drugs. Clin Res Cardiol 2016;105:755-762.
Go to original source...
Go to PubMed...
- Bulsei J, Darlington M, Durand-Zaleski I, et al. How to perform a cost-effectiveness analysis with surrogate endpoint: renal denervation in patients with resistant hypertension (DENERHTN) trial as an example. Blood Press 2018;27:66-72.
Go to original source...
Go to PubMed...
- Rosa J, Widimský P, Waldauf P, et al. Renal denervation in comparison with intensified pharmacotherapy in true resistant hypertension: 2-year outcomes of randomized PRAGUE-15 study. J Hypertens 2017;35:1093-1099.
Go to original source...
Go to PubMed...
- Widimský P, Filipovský J, Widimský Jr J, , et al. Expert consensus statement of the Czech Society of Cardiology and the Czech Society of Hypertension on catheter-based sympathetic renal denervation procedures (RDN) in the Czech Republic. Cor Vasa 2012;54:e108-e112.
Go to original source...
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.